Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease

Joseph Pierre Aboumsallem; Javid Moslehi; Rudolf A de Boer

doi:10.1161/JAHA.119.013754

Reverse Cardio-Oncology: Cancer Development in Patients With Cardiovascular Disease

J Am Heart Assoc. 2020 Jan 21;9(2):e013754. doi: 10.1161/JAHA.119.013754. Epub 2020 Jan 21.

Authors

Joseph Pierre Aboumsallem¹, Javid Moslehi^{2

3}, Rudolf A de Boer¹

Affiliations

¹ Department of Cardiology University Medical Center Groningen University of Groningen the Netherlands.
² Division of Cardiovascular Medicine Clinical Pharmacology Cardio-Oncology Program Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center Nashville TN.
³ Division of Oncology Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center Nashville TN.

No abstract available

Keywords: biomarker; cancer; cardiokines; cardiovascular disease; cardio‐oncology; inflammation; reverse cardio‐oncology; risk factor; somatic mutations.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Cardiology*
Cardiovascular Diseases / epidemiology*
Cardiovascular Diseases / metabolism
Cardiovascular Diseases / physiopathology
Cardiovascular Diseases / therapy
Humans
Incidence
Inflammation / epidemiology
Inflammation / metabolism
Inflammation / physiopathology
Inflammation / therapy
Inflammation Mediators / metabolism
Medical Oncology*
Neoplasms / epidemiology*
Neoplasms / metabolism
Neoplasms / physiopathology
Neoplasms / therapy
Prevalence
Prognosis
Risk Assessment
Risk Factors
Signal Transduction
Specialization
Tumor Hypoxia
Tumor Microenvironment

Substances

Inflammation Mediators